We study a class of discrete SIRS epidemic models with nonlinear incidence rate ( ) ( ) and disease-induced mortality. By using analytic techniques and constructing discrete Lyapunov functions, the global stability of disease-free equilibrium and endemic equilibrium is obtained. That is, if basic reproduction number R 0 < 1, then the disease-free equilibrium is globally asymptotically stable, and if R 0 > 1, then the model has a unique endemic equilibrium and when some additional conditions hold the endemic equilibrium also is globally asymptotically stable. By using the theory of persistence in dynamical systems, we further obtain that only when R 0 > 1, the disease in the model is permanent. Some special cases of ( ) ( ) are discussed. Particularly, when ( ) ( ) = /(1 + ), it is obtained that the endemic equilibrium is globally asymptotically stable if and only if R 0 > 1. Furthermore, the numerical simulations show that for general incidence rate ( ) ( ) the endemic equilibrium may be globally asymptotically stable only as R 0 > 1.
Introduction
During the past decades, no matter discrete epidemic models or continuous epidemic models, have been widely studied. Many important and interesting results can be found in and the references cited therein. The main research subjects are the computation of the threshold value or basic reproduction number which distinguishes whether the infectious disease will persist or die out, the local and global stability of the disease-free equilibrium and endemic equilibrium, the extinction, persistence, and permanence of the disease, and the bifurcations, chaos, and more complex dynamical behaviors of the models.
Among these questions, global stability of equilibria has always been one of the research focuses and difficult problems. Many authors have investigated this question using the second Lyapunov method (see [29] ). The most popular types of Lyapunov functions candidate for population biology models are the Volterra-type functions − * − ln( / * ) and the quadratic function ( /2)( − * ) 2 . The former has been successfully applied for various disease propagation models by Korobeinikov and his coworkers (see [7] [8] [9] [10] and the references cited therein). In [11] , Li et al. presented an algebraic approach to prove the global stability, which can provide the method of constructing a Lyapunov function and prove the negative definiteness of the derivative. Recently, by combining Volterra functions and quadratic functions, Vargas-De-León has studied global stability of classic continuous SIS, SIR, and SIRS epidemic models with constant recruitment, disease-induced death, and standard incidence rate and bilinear incidence rate in [12, 13] , respectively. McCluskey in [14] [15] [16] introduced the Lyapunov functional formed as ∫ 0 ( ( − )/ * −1−ln( ( − )/ * )) to investigate global stability of endemic equilibrium of SEIR epidemic model with distributed delay or discrete delay. It is well known that a crucial role in mathematical models of infectious disease is played by the so-called incidence rate, namely, a function describing the mechanism of transmission of the disease. In most epidemiological models, bilinear incidence rate and standard incidence rate / are frequently used, where is the total number of the population ( = + + ) and > 0 is the per capita contact rate. These incidences imply that the contact number between and is proportional to or / . But the infection probability per contact is likely influenced by the number of infective and susceptible individuals, because more infective individuals can increase the infection risk and susceptible individuals would avoid the contact with infective individuals. Therefore, a number of nonlinear incidence rates are suggested by researchers. After studying the cholera epidemic spread in Bari in 1973, Capasso and Serio [17] introduced the saturated incidence rate ( ) into epidemic models. To incorporate the effect of the behavioral changes of the susceptible individuals, Liu et al. proposed the general incidence rate /(1+ ) in [18] , where , > 0 and ≥ 0. The special cases when and are given different values have been used by many authors (see, e.g., Korobeinikov and Maini [6] , Ruan and Wang [19] , and Xiao and Ruan [20] ).
However, until now, to the best of our knowledge, there are few search results about global stability of equilibria for discrete SIRS model with nonlinear incidence rate. Hu et al. in [28] discussed local stability and complex dynamical behaviors for a class of discrete SIRS epidemic models with general nonlinear incidence rate discretized by the forward Euler scheme. Enatsu et al. in [22] proposed a class of discrete SIR epidemic models with bilinear incidence rate, which are derived from continuous SIR epidemic models with distributed delays by using a variation of the backward Euler method, and obtained that global stability of diseasefree equilibrium and endemic equilibrium. Muroya et al. in [23] discussed global stability and permanence of a discrete epidemic model with bilinear incidence rate and for disease with immunity and latency spreading in a heterogeneous host population, which is also discretized from the continuous case by using the backward Euler method. In [24] , Enatsu et al. studied a class of discrete SIR epidemic models with nonlinear incidence rates and distributed delays, which are derived from the corresponding continuous SIR epidemic models by applying a variation of the backward Euler discretization. Using discrete-time analogue of Lyapunov functionals, the global asymptotic stability of the diseasefree equilibrium and endemic equilibrium is fully determined by the basic reproduction number 0 , when the infection incidence rate has a suitable monotone property.
Motivated by the fact that discrete epidemic models are more appropriate approach to understand disease transmission dynamics and to evaluate eradication policies because they permit arbitrary time step units, preserving the basic features of corresponding continuous models, in this paper, we will extend a discrete-time analogue of Lyapunov techniques proposed in [25] [26] [27] to the following discrete SIRS epidemic models with nonlinear incidence rate ( ) ( ), which is established by using the backward Euler scheme (see [30, 31] ) to discretize the corresponding continuous SIRS epidemic model: (1)
We will investigate the global behaviors of solutions of model (1) . By constructing new discrete Lyapunov functions, we will establish some new criteria on the global asymptotic stability of the disease-free equilibrium and endemic equilibrium for model (1) . By using the theory of persistence in dynamical systems, we will further obtain the sufficient and necessary conditions for the permanence of the disease for model (1) .
The organization of this paper is as follows. In Section 2, the existence of equilibria and positivity of solutions for model (1) are given. In Section 3, the results on the global asymptotic stability of the disease-free equilibrium and endemic equilibrium for model (1) are stated and proved. In Section 4, the results on the permanence of the disease in model (1) are established. In Section 5, the global asymptotic stability of the endemic equilibrium of model (1) for the special case ( ) = /(1 + ) is discussed. Finally, some examples are given to illustrate the main theoretical results in Section 6.
Equilibria and Positivity
For model (1), ( ), ( ), and ( ) represent the numbers of susceptible, infectious, and recovered individuals at th generation, respectively. The parameters Λ, , , and are positive constants and is nonnegative constant in which Λ is the recruitment rate into the population, is the natural death rate, is the disease-induced death rate, is the recovery rate of the infectious individuals, is the rate of losing immunity, > 0 implies that the recovered individuals would lose the immunity, and = 0 implies that the recovered individuals acquire permanent immunity. The spread of disease can be described by general form with incidence rate ( ) ( ); that is, the incidence rate depends on the number of the susceptible individuals and the number of the infectious individuals. This generalizes the bilinear incidence rate (i.e., ( ) ( ) = ), saturated incidence rate with respect to (i.e., ( ) ( ) = /(1 + )), and saturated incidence rate with respect to (i.e., ( ) ( ) = /(1 + )), where > 0, ≥ 0, and ≥ 0 are constants, which denotes the contact coefficient and the saturated coefficient, respectively.
The initial condition for model (1) is given by
In this paper, for functions ( ) and ( ), we firstly introduce the following assumption.
( 1 ) ( ) and ( ) are positive, monotonically increasing, and continuous differentiable functions defined for all ≥ 0 and ≥ 0, the derivative (0) exists, and (0) = (0) = 0. Furthermore, ( )/ is nonincreasing for all > 0.
is basic for model (1) . In fact, for many special cases of ( ) ( ), for example, ( ) ( ) = , ( ) ( ) = /(1 + ), and ( ) ( ) = /(1 + ), ( 1 ) is always satisfied.
In order to obtain the existence of disease-free equilibrium and endemic equilibrium of model (1), we introduce a constant
We have the following result.
Theorem 2.
Assume that ( 1 ) holds.
(1) When R 0 ≤ 1, then model (1) has only a unique disease-free equilibrium 0 (Λ/ , 0, 0). 
Proof. Obviously, model (1) always has a disease-free equilibrium 0 (Λ/ , 0, 0). From (4), we have * = * + , Λ=
Hence, * = 1 (Λ −
and from the second equation of (4) we further have * ( + + ) = ( Λ − * ( + ) ( + ) + ( + ) ) ( * ) .
When > 0, let
Then by ( 1 ) we obtain 
and then * ( * , * , * ) is a unique endemic equilibrium of model (1) . This completes the proof.
From Theorem 2, we can claim that the basic reproduction number of model (1) is R 0 . On the positivity and ultimate boundedness of solutions of model (1), we obtain the following theorem. 
( + 1) = ( ) + Λ − ( ( + 1)) ( ( + 1))
In the following, we will use the induction to prove the positivity of ( ( ), ( ), ( )). When = 0, we have
(1) = (0) + Λ − ( (1)) ( (1)) − (1) + (1) .
From (13)- (15) we see that as long as (1) is confirmed, then (1), (1), and (1) will be whereafter confirmed. Firstly, we prove that if (1) > 0, then (1) > 0 and (1) > 0. From (14), we directly obtain (1) > 0 when (1) > 0. Let = (1), and from (15) we obtain
It is obvious that, when ( Let = (1)); then from (13) we see that must satisfy the following equation:
where 
there exists a unique ∈ (0, 0 ) such that Ψ( ) = 0. Now, we show that is a unique solution of When = 1, we obtain
Obviously, using a similar argument in the above process, we also can obtain (2) > 0, (2) > 0, and (2) > 0. Lastly, by using the induction, we can finally obtain ( ) > 0, ( ) > 0, and ( ) > 0 for all > 0.
From the third equation of model (11), we have
Since comparison equation,
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Therefore, ( ( ), ( ), ( )) is also ultimately bound. This completes the proof.
Global Stability
Now, we are concerned with the global asymptotic stability of disease-free equilibrium 0 and endemic equilibrium * of model (1), respectively. Proof. Calculating the linearization system of model (1) at equilibrium 0 , we have
From the second equation of system (25), we have
When R 0 < 1, we obtain
Therefore, lim → ∞ V = 0. By
we further obtain lim → ∞ = 0 and lim → ∞ = 0. This shows that 0 is locally stable when R 0 < 1. Since the case R 0 = 1 is a critical one for model (1) , in the following, we discuss global attractivity of disease-free equilibrium 0 when R 0 ≤ 1.
Let ( ( ), ( ), ( )) be any positive solution of model (1) with initial conditions (2) . We need to consider the following two cases. 
From third equation of (11), we further obtain
For Case 2, by using the iterative computations to inequality (22) , we can obtain ( ) < Λ/ for all ≥ 1 . Hence, ( ) < Λ/ for all ≥ 1 . From ( 1 ), we further obtain
Since
from the second equation of model (1), it follows that, for all
If R 0 ≤ 1, then
Hence, ( ) is nonincreasing for ≥ 1 . Consequently, lim → ∞ ( ) =̂exists and̂≥ 0.
Supposê> 0; then from the second and third equations of model (11), we can obtain that lim → ∞ ( ) and lim → ∞ ( ) exist, and
From ( ) = ( )− ( )− ( ), it follows that lim → ∞ ( ) = exists. Obviously, we havê> 0,̂≥ 0, and̂≥ 0. Hence, (̂,̂,̂) is an equilibrium of model (1). However, from Theorem 2, we see that when R 0 ≤ 1, (36) only has a unique solution̂= Λ/ ,̂= 0, and̂= 0. This leads to a contradiction. Therefore, we havê= 0.
Therefore, we always have lim → ∞ ( ) =̂= 0. By (35), it follows that lim → ∞ ( ) = 0 and lim → ∞ ( ) = Λ/ . Consequently, lim → ∞ ( ) = Λ/ . This shows that diseasefree equilibrium 0 = (Λ/ , 0, 0) is globally attractive when R 0 ≤ 1. This completes the proof.
In order to obtain the global asymptotic stability of endemic equilibrium * of model (1), we need the following assumptions.
Proof. We firstly define the auxiliary functions as follows:
where = + + and
and when
Let ( ( ), ( ), ( )) be any positive solution of model (1) with initial condition (2) . By computing Δ 1 ( ) = 1 ( ( + 1)) − 1 ( ( )), we have
From ( 1 ), it follows that
Hence,
By computing Δ 2 ( ) = 2 ( ( + 1)) − 2 ( ( )), we also have
Further, by computing Δ 3 ( ) = 3 ( ( + 1)) − 3 ( ( )), we have
Finally, by computing Δ 4 ( ) = 4 ( ( + 1), ( + 1)) − 4 ( ( ), ( )), we further have 
Now, we define a Lyapunov function as follows:
where 1 and 2 are positive constants which will be chosen in the following. It is obvious that from (40) 
we have
Choose constants 1 and 2 as follows:
Then we further have
Noting that ( ) > 0, for all > 0, then we have
From ( 1 ), it follows that ( ( +1)) ≥ ( * ) when ( +1) ≥ * and ( ( + 1)) ≤ ( * ) when ( + 1) ≤ * . Hence, we have the following inequality:
Furthermore, from ( 1 ), we also have the following inequalities:
which implies that
From (53), (54), and (56), we further obtain
From ( 2 ) and ( 3 ), we finally have Δ ( ) ≤ 0 for all ≥ 0. Obviously, Δ ( ) = 0 if and only if ( ) = * , ( ) = * , and ( ) = * for all ≥ 0. Therefore, using the theorems of stability of the difference equations (see Theorem 6.3 in [33] ), we obtain that * is globally asymptotically stable. This completes the proof.
As a special case of model (1), we consider the rate of losing immunity = 0 in model (1) ; that is, model (1) degenerates into a SIR epidemic model. Then, in the above calculation of Δ ( ), we can directly obtain the following inequality without ( 2 ) and ( 3 ):
We have Δ ( ) ≤ 0 for all ≥ 0 and Δ ( ) = 0 if and only if ( ) = * and ( ) = * for all ≥ 0. Therefore, as a consequence of Theorem 5, we have the following result. 
Remark 7.
By comparing the results obtained in [24] , then, from Corollary 6, we see that Theorem 5 is a direct extension of the corresponding result given in [24] on the global stability of the endemic equilibrium in the nondelayed case and the recovered individuals are in a position to lose the immunity.
Remark 8.
For general model (1), we spontaneously expect that as long as basic reproduction number R 0 > 1, then model (1) shows a unique endemic equilibrium which is globally asymptotically stable. However, it is a pity that, in Theorem 5, in order to obtain the global asymptotic stability of endemic equilibrium * , we need to introduce some additional conditions, that is, ( 2 ) and ( 3 ). Furthermore, from the proof of Theorem 5, we easily see that assumptions ( 2 ) and ( 3 ) only are used to ensure Δ ( ) ≤ 0 for all ≥ 0. Therefore, an important open problem is whether we can directly prove Δ ( ) ≤ 0 for all ≥ 0 without assumptions ( 2 ) and ( 3 ) and further obtain the global asymptotic stability of endemic equilibrium * of model (1) only when basic reproduction number R 0 > 1.
Permanence of Disease
In this section, we will use the theory of persistence in general discrete dynamical systems to study the permanence of model (1). We will obtain that the disease in model (1) is permanent only when basic reproduction number R 0 > 1 and assumption ( 1 ) holds.
Let be a metric space with metric and let : → be a continuous map. For any 0 ∈ , the sequence { } defined by +1 = ( ) for any integer ≥ 0 is said to be a solution sequence through 0 , and the omega limit set of { } is defined by ( 0 ) = { ∈ : there is a sequence → ∞ such that lim → ∞ = }. For a nonempty set ⊂ , we further define the stable set of by ( ) = { 0 ∈ : lim → ∞ ( , ) = 0}.
Let 0 be a nonempty open set of . We denote Here, the definitions on the compactness and point dissipativity of map and the definitions on the compactness, isolated invariance, and the cycle in 0 for sequence M = { 1 , . . . , } can be found in [34] . Furthermore, Lemma 9 can be obtained from Theorem 1.1.3, Theorem 1.3.1, Remark 1.3.1, and Theorem 1.3.3 given by Zhao in [34] .
On the permanence of the disease for model (1), we have the following result. Proof. From Theorem 4 we see that the necessity is obvious. Now, we only need to prove the sufficiency. Define two sets as follows:
We have
For any initial point 0 = ( 0 , 0 , 0 ) ∈ , let = ( ( ), ( ), ( )) be the solution of model (1) through 0 . We define map : → by ( 0 ) = 1 .
From the positivity and ultimate boundedness of solutions of model (1), we obtain ( 0 ) ⊆ 0 and is also point dissipative.
By observing the proof of Theorem 3, we see that, since (1) and (1) are continuous with respect to (0) and (0), respectively, Ψ( ) is also continuous with respect to 0 = ( 0 , 0 , 0 ). Hence, (1), as the solution of Ψ( ) = 0, is also continuous for 0 . Similarly, from the expression of Φ( ) and the continuity of (1) with respect to 0 , we obtain that Φ( ) is continuous with respect to 0 . Hence, (1), as the solution of Φ( ) = 0, is also continuous for 0 . Therefore, we finally obtain that map is continuous on . From this, we obtain that also is compact.
In 0 , we have ( ) ≡ 0, and hence ( ( ), ( )) satisfies
Obviously, we can obtain ( ( ), ( )) → (Λ/ , 0) as → ∞. This shows that ( 0 ) = { 0 } for any 0 ∈ and Ω( ) = ⋃ ∈ ( ) = { * }. Choose M = { 0 }; then we easily see that conditions (a)-(c) of Lemma 9 hold. Now, we prove that condition (d) in Lemma 9 also holds. Otherwise, there is a point 
for all > . Consequently,
for all > . Since 0 ≤ 1+ + + −( (Λ/ )− )( (0)− ) < 1, we can finally obtain from (66) that lim → ∞ ( ) = ∞, which leads to a contradiction. Therefore, condition (d) in Lemma 9 holds. Finally, from Lemma 9 we obtain that the disease in model (1) is permanent. This completes the proof.
Remark 11. From Theorem 10, we directly see that assumptions ( 2 ) and ( 3 ) only are used to obtain the global asymptotic stability of endemic equilibrium * .
Special Case ( ) = / (1 + )
Now, we especially discuss the special case of model (1): ( ) = /(1 + ), where ≥ 0 is a constant. Firstly, when ( ) = /(1 + ), the basic reproduction number of model (1) becomes
Furthermore, by calculating, we obtain that ( 2 ) naturally holds, and assumption ( 3 ) is equivalent to the following simple form: * − * ≤ 0.
Therefore, as a direct consequence of Theorem 5, we firstly have the following corollary. 
Proof. When ( ) ( ) = ( /(1 + )) ( ), endemic equilibrium * ( * , * , * ) of model (1) satisfies
From the second and third equations of (70), we obtain * = * ( + + )
Putting ( 
Since ( )/ is nonincreasing for all > 0 in ( 1 ), we have 
From (75), we obtain that, when the conditions of Theorem 10 hold, * − * ≥ 0. Therefore, inequality (68) holds. This completesthe proof.
Remark 14.
Obviously, from the above discussion for special case ( ) = /(1+ ) of model (1), we also have an important open problem, that is, whether endemic equilibrium * of model (1) is globally asymptotically stable as long as basic reproduction number R 0 > 1.
In the following, we will give an affirmative answer for above open problem in allusion to ( ) = and ( ) = /(1 + ) in model (1), by constructing the other Lyapunov function which is different from the Lyapunov function used in Theorem 5.
Firstly, we see in model (1) when ( ) = and ( ) = /(1 + ), where > 0 and ≥ 0 are two constants, basic reproduction number
and assumption ( 1 ) naturally holds. Therefore, from Theorem 2, when R 0 > 1, model (1) Proof. We consider the following Lyapunov function: 
a similar argument as in calculation Δ 3 ( ) in Theorem 5, we obtain
By using inequality ln(1 − ) ≤ − for any < 1, we obtain
) . 
Since * ( * , * , * ) satisfies
then from (81) we further have
Therefore, we finally get that Δ ( ) ≤ 0 for all ≥ 0. Obviously, Δ ( ) = 0 if and only if ( + 1) = * , ( + 1) = * , and ( + 1) = * . Therefore, from the theorems of stability of difference equations (see Theorem 6.3 in [33] ), we obtain that * is globally asymptotically stable. This completes the proof. Remark 17. In [13] , the author studied a continuous SIRS epidemic model with bilinear incidence rate and obtained that the disease-free equilibrium is globally stable if basic reproduction number 0 ≤ 1 and the endemic equilibrium is globally stable if 0 > 1. However, in this paper, we established the completely same results for the corresponding backward Euler discretization model with saturation incidence rate. This shows that the results obtained in [13] are extended and improved in the discrete models.
Remark 18. In [25] , the following continuous SIRS epidemic model with a class of nonlinear incidence rates and distributed delays is considered: [25] for nondelayed discrete SIRS epidemic model with nonlinear incidence rate ( ) ( ).
However, we also see whether the conclusions obtained in [25] can be extended to delayed discrete SIRS epidemic models with more general nonlinear incidence rate ( , ), which is left to further investigation in our future work.
Numerical Simulations
In this section, we give the following examples and numerical simulations for model (1) .
We choose Λ = 3, = 0.2, = 1, = 0.8, = 0.2, = 0.5, and = 0.3. By calculating, we have the endemic equilibrium * = (7, 3.2941, 1.4118)) and the basic reproduction number R 0 = Λ ( + + ) ( + Λ) = 1.0714 > 1.
However, * − * = −0.6941 < 0. Clearly, inequality (56) does not hold. From the numerical simulation (see Figure 1) , we obtain that the endemic equilibrium * is still globally asymptotically stable. Therefore, in our future work, we expect to obtain the corresponding theoretical result for the open problem in Remark 8. 
By further computation, we obtain, when = 2. 
and, when = 3.064, 
That is, neither ( 2 ) nor ( 3 ) holds. However, from the numerical simulation (see Figure 2) , it is clear that the endemic equilibrium * is still globally asymptotically stable. Therefore, in our future work, we expect to obtain the corresponding theoretical result for the open problem in Remark 8. 
Conclusions
This paper deals with global stability of disease-free equilibrium and endemic equilibrium and the permanence of disease for a class of discrete SIRS epidemic models with nonlinear incidence rate ( ) ( ) and disease-induced mortality. Under the basic assumption ( 1 ), by applying analytic techniques, we obtain that disease-free equilibrium 0 of model (1) is globally asymptotically stable if basic reproduction number R 0 ≤ 1 and disease in the model is permanent if R 0 > 1. Furthermore, motivated by the recent progress of Lyapunov techniques in continuous epidemic models (see, e.g., [25] [26] [27] ), we construct the corresponding discrete analogue of Lyapunov functions (see Theorem 4) for nonlinear incidence rate ( ) ( ). Under the assumptions burdened on ( ), that is, assumptions ( 2 ) and ( 3 ), we prove that the global asymptotic stability for endemic equilibrium * of model (1) for the case R 0 > 1 is an extension of SIR-type models with nonlinear incidence rate ( ) ( ) (see, for instance, [7, 26] , etc.); that is, when SIRS models degenerate into SIR models, endemic equilibrium of the corresponding SIR models is globally asymptotically stable only if R 0 > 1 and basic assumption ( 1 ) hold.
From the proof of theorems in this paper, we easily see that discrete Lyapunov functions, such as ( , , ) in Theorem 5, also can be applied for advanced models, including the models with delay. We expect to study the global stability of discrete SIRS and SEIRS epidemic models with rather general incidence rate ( , ) and with discrete or infinite delay, which is left as a future work.
